PRESENTATION
1 – Message from the organizing committee.

ORAL
2 – MAMMOGRAPHY FOR BREAST CANCER SCREENING IN BRAZIL: A CURRENT PROFILE.
Karla O. Elesbão, Felipe Z. Pereira, Victória O. Prados, Pedro Paulo D. Soares, Maria Angélica E. Franco, Fabiane A. Carvalho.

3 – HIGH RISK FOR CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL BREAST CANCER SURVIVORS.
Daniel A. B. Buttros , Mauro T. Branco , Benedito S. A. Filho , Jorge Nahás-Neto , Eliana A. P. Nahás.

4 – EPIDEMIOLOGICAL PROFILE OF BREAST CANCER IN MEN IN BRAZIL BETWEEN 2008 AND 2018.
Felipe Z. Pereira, Karla O. Elesbão, Victória O. Prados, Fabiane A. Carvalho.

5 – PERI-LYMPH NODAL PATHOLOGICAL FIBROSIS AND AXILLARY SURGICAL IMPAIRMENT AFTER 14G PERCUTANEOUS FRAGMENT BIOPSY OF SENTINEL LYMPH NODE DETECTED WITH CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN EARLY BREAST CANCER PATIENTS.
Nicoli Serquiz, Carlos A. Menossi, Natalie R. Almeida, Gabrielle Baccarin, Geisilene R. P. Silva, Luciano Moro, Sophie Derchain, Rodrigo M. Jales.

6 – CLINICAL QUALITY CONTROL OF MAMMOGRAMS EVALUATED IN A BRAZILIAN TERTIARY HOSPITAL.
Leonardo R. Soares, Rosemar M. S. Rahal, Victória C. J. Queiroz, Erika C. Aquino, Rosangela S. Correa, Danielle C. N. Rodrigues, Ruffo Freitas-Junior.

7 – LATE RESULTS OF REGIONAL BREAST CANCER SCREENING PROGRAM PERFORMED IN THE INTERIOR OF SÃO PAULO STATE, BRAZIL.
Idam Oliveira-Junior, Edmundo C. Mauad, Bruno O. Fonseca, Anapaula H.U. Watanabe, René A.C.Vieira Barretos Câncer Hospital – Barretos (SP), Brazil.

8 – ONCOPLASTIC SURGERY IN THE CONSERVATIVE TREATMENT OF THE LOCALLY ADVANCED BREAST CANCER: A SISTEMATIC REVIEW.
Daniela C.C.C. E. Ribeiro, Cláudia A. A. Góes, Naiana S. C.Andrade, Lucas G. Ramos, Luiz Fernando J. Ribeiro, Régis R. Paulinelli.

9 – ANALYSIS OF BOOST VOLUME DEFINITION IN RADIATION THERAPY FOR CONSERVATIVE BREAST SURGERY.
Thiago Brasileiro de Freitas, Kennya Medeiros Lopes de Barros Lima, Heloísa de Andrade Carvalho, Alexandre Siqueira Franco Fonseca, Alexandre Mendonça Munhoz, José Roberto Filassi, Silvia R. Stuart, Gustavo Nader Marta.

10 – EXPRESSION OF β-CATENIN AND E-CADHERIN IN BREAST DUCTAL CARCINOMA IN SITU AND THEIR ASSOCIATION WITH SURVIVAL: FOLLOW UP OF 9.0 YEARS.
Giuliano M. Duarte, Helena Slongo, Marcelo L. Montenegro, Fernando Tocchet, Juliana Espinola, Fernando Augusto Soares, Priscila Marshall, Geisilene R. P. Silva.

11 – PHASE II CLINICAL TRIAL, TESTING THE EFFICACY OF A HUMANIZED MONOCLONAL ANTIBODY AGAINST THE LEWIS-Y ANTIGEN (LE Y).
Laura Testa, Ruffo Freitas-Junior, Sergio V Serrano, Roberto J Arai, Marina C Zorzetto, Oren Maletz, Max S Mano, Paulo M Hoff.

12 – TRANSCRIPTION EXPRESSION OF IL-6 AND IL-1β GENES AND ITS RELATION WITH THE EFFICACY OF CHEMOTHERAPY IN WOMEN WITH BREAST CANCER.
Jéssica P. Oliveira, Isis D. D. Custódio, Alinne T. F. Câmara, Izabella C. C. Ferreira, Marceila A. Fuzissaki, Thaise G. de Araújo, Luiz R. Goulart, Yara C. P. Maia.

13 – ASSOCIATION OF ONCOGENE RAC 1 WITH HER-2 TUMORS AND WITH AGGRESSIVITY OF TRIPLE NEGATIVE TUMORS.
Maria Amelia Carlos Souto Maior Borba, Joana Darc Rosendo dos Santos, Nancy Cristina Ferraz de Lucena Ferreira, Darley de Lima Ferreira Filho, Glauber Moreira Leitão, Danyelly Bruneska Gondim Martins.

14 – TWIST1 KNOCKDOWN ELUCIDATES THE REGULATION OF TH17-LIKE RESPONSE IN HER2 BREAST CANCER SUBTYPE.
Bruno R. B. Pires, Renata Binato, Gerson M. Ferreira, Barbara Du Rocher, Stephany Corrêa, Daniel Bulzico, Eliana Abdelhay.

15 – ANALYSIS OF PEAK TORQUE OF WOMEN TREATMENT CHEMOTHERAPY WITH APPARENTLY HEALTHY WOMEN.
Vitor Marques, Rafael Alves, Thaynã Guimarães, Rafael Moraes, Weder Silva, Danielly Dias, Camila Seguro, Carlos Vieira.

16 – ANALYSIS OF A SYNONYMOUS SINGLE NUCLEOTIDE VARIANT IN PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA GENE IN TRIPLE NEGATIVE BREAST CANCER .
Joana D. R. Santos, Nancy C. F. L. Ferreira, Darley L. F. Filho, Cintia R. C. Rocha, Carlos H. M. Castelletti, José L. L. Filho1, Danyelly B. G. Martins.

COMMENTED POSTER

17 – INVESTMENT OF THE UNIFIED HEALTH SYSTEM IN SCREENING MAMMOGRAPHY IN BRAZIL, 2008–2017.
Danielle Cristina Netto Rodrigues, Ruffo Freitas-Junior, Rosemar Macedo Sousa Rahal, Luiz Paulo da Silveira Corrêa, Rosangela da Silveira Corrêa.

18 – RETURN TO WORK ITS IMPACT ON THE QUALITY OF LIFE OF BRAZILIAN BREAST CANCER PATIENTS.
Isabela C. F. Colombino, Idam Oliveira-Junior, Fabiola C. B. Silva, Jonathas J. Silva, Almir J. Sarri, Rene A. C. Vieira.

19 – AGE OF DIAGNOSIS AND BODY MASS INDEX IN BREAST CANCER PATIENTS: ANALYSIS OF A BRAZILIAN REFERENCE CENTRE.
Luiz Henrique Gebrim, André Mattar, Jorge Y. Shida, Roberto Hegg, Ana Luiza A. Faria, Felipe A. Cavagna.

20 – MICRORNAS AS BIOMARKERS FOR BREAST CANCER PROGNOSIS: A SYSTEMATIC REVIEW.
Bárbara A.S. Soares, Cesar A.S.T. Vilanova-Costa, Deidimar C.B. Abreu, Vera A. Saddi.

21 – EFFECTS OF [10]-GINGEROL IN COMBINATION WITH DOXORUBICIN ON TRIPLE NEGATIVE BREAST CANCER IN VITRO AND IN VIVO.
Ana Carolina B.M. Martin, Rebeka Tomasin, Marina de Araújo Naves, Angélica Graminha, Liany Luna-Dulcey, Ramon H.G. Teles, Márcia Regina Cominetti1.

22 – ANALYSIS OF POLYMORPHISMS IN THE TP53 GENE IN PATIENTS WITH CLINICAL DIAGNOSIS FOR HEREDITARY BREAST CANCER .
Paula F. F. Silva, Rebeca M. Goveia1, Thais B. Teixeira, Hugo Deleon, Gabrielly R. Abrantes1, Kézia A. Delmond, Aliny P. de Lima, Jeffter R. Silva, Elisângela de P. S. Lacerda.

23 – COMPARISSON BETWEEN MORPHOLOGICAL ASPECTS ON THE MAMMARY ULTRASSONOGRAPHY OF BREAST MALIGNANT NEOPLASIES AND THE IMMUNOHISTOCHEMISTRY PROFILE OF THESE TUMORS.
Alexandre V. de Andrade, Ricardo M. Neto, Renato S. Discini, Luis C. F. de Almeida, Juliana A. Fermolli, Gabriela B. C. Silva.

24 – TNM8 BREAST CANCER CALCULATOR: A TOOL FOR BREAST CANCER STAGING ACCORDING TO THE TNM 8TH EDITION.
Wesley Pereira Andrade.

25 – PROSPECTIVE STUDY OF POSTOPERATIVE WHOLE BREAST RADIOTHERAPY FOR PATIENTS WITH LARGE AND PENDULOUS BREAST: A CLINICAL AND DOSIMETRIC COMPARISONS BETWEEN SUPINE AND PRONE POSITIONS.
Izabela Lourenço Silva Fernandes, José Maria Fernandes Júnior, Marcelo Luvizotto Alcântara de Pádua, Marília Ferreira Andrade, Nayara Ferreira Cunha, Marcela Carrijo Setti, Fredstone Rodrigues da Cunha.

26 – HAND2 AND ER EXPRESSION IN BREAST CANCER.
Quiti. Lopes, Ernesto de Paula Guedes Neto, José Luiz Pedrini, Ricardo Francalacci Savaris.

27 – EFFECTIVENESS OF DIFFERENT ACCELERATED PARTIAL BREAST IRRADIATION TECHNIQUES FOR THE TREATMENT OF BREAST CANCER PATIENTS: SYSTEMATIC REVIEW USING INDIRECT COMPARISONS OF RANDOMIZED CLINICAL TRIALS [EFFECTIVENESS OF DIFFERENT APBI TECHNIQUES].
Gustavo Nader Marta, Gustavo José Martiniano Porfirio, Ana Luiza Cabrera Martimbianco, Jessica Barrett, José Luiz Barbosa Bevilacqua, Philip Poortmans, Rachel Riera.

28 – THE ROLE OF PALLIATIVE RADIOTHERAPY IN LOCALLY ADVANCED BREAST CANCER REFRACTORY TO NEOADJUVANT CHEMOTHERAPY AND UNRESECTABLE.
Ana Flávia de Paula Guerra Campedelli, Nilceana Aires Maya Freitas, Thais Franco Simionatto, Nathalya Ala Yagi, Jean Teixeira de Paiva, Carolina Martinelli Bezerril.

29 – THE IMPACT OF RADIODERMATITIS IN QUALITY OF LIFE OF PATIENTS WITH BREAST CANCER DURING TREATMENT: A PROSPECTIVE LONGITUDINAL STUDY.
Marceila A. Fuzissaki, Carlos E. Paiva, Marco A. Oliveira, Mariana T. M. Lima, Paula P. L. Canto, Yara C. P. Maia.

30 – A PROTECTIVE EFFECT OF MORNING RADIOTHERAPY ON SKIN TOXICITY IN PATIENTS WITH BREAST CANCER.
Marceila A. Fuzissaki, Carlos E. Paiva, Marco A. Oliveira, Mariana T. M. Lima, Paula P. L. Canto, Yara C. P. Maia.

31 – EXPRESSION OF PRO- AND ANTIANGIOGENIC VEGF-A ISOFORMS AND SPLICING REGULATORY FACTORS IN BREAST CANCER.
Rodrigo Castro, Beatriz P. Bertelli, Patrícia M. Biselli-Chicote, Dalísio S. Neto, José Luis E. Francisco, Érika C. Pavarino, Eny M. Goloni-Bertollo.